Megmento Pharmaceutical Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glipament MV 1 Tablet ER is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet ER
Glipament MV 1 Tablet ER is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glipament MV 1 Tablet ER is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glipament MV 1 Tablet ER.
Glipament MV 1 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glipament MV 1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glipament MV 1 Tablet ER is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. Carry a sugar source with you for immediate relief in case of hypoglycemia (low blood sugar level). Your doctor may check your liver function regularly.
Glipament MV 1 Tablet ER contains three active ingredients: Glimepiride, Metformin, and Voglibose. It's used to treat Type 2 diabetes mellitus (DM). This medication helps lower blood sugar levels in adults when combined with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas. Metformin reduces glucose production by the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination does not treat Type 1 DM.
Common side effects of Glipament MV 1 Tablet ER include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. Seek medical attention if you experience any severe or prolonged side effects.
Do not use Glipament MV 1 Tablet ER if you are allergic to any of the ingredients or excipients. It's also not suitable for people with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcers, or underlying metabolic acidosis including diabetic ketoacidosis.
No, alcohol should not be taken concurrently with Glipament MV 1 Tablet ER. It may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glipament MV 1 Tablet ER can cause hypoglycemia (low blood sugar levels). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications with it. Monitoring blood sugar levels regularly is crucial and always keep glucose tablets, honey, or fruit juice handy.
Store this medication in its original packaging, tightly closed. Refer to the label or the package for specific storage instructions. Do not consume leftover medication by yourself, pets, children, or others.